• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与乙肝病毒感染母亲在孕期服用核苷(酸)类似物后不遵守母乳喂养建议相关的因素:一项回顾性调查。

Factors associated with non-compliance with breastfeeding recommendation: a retrospective survey in hepatitis B virus-infected mothers who had taken Nucleos(t)ide analogs during pregnancy.

机构信息

Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangdong Province, 510630, Guangzhou, China.

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 510120, Guangzhou, China.

出版信息

BMC Pregnancy Childbirth. 2021 Aug 12;21(1):551. doi: 10.1186/s12884-021-04020-z.

DOI:10.1186/s12884-021-04020-z
PMID:34384374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8359301/
Abstract

BACKGROUND

We encourage Hepatitis B virus-infected mothers to breastfeed postpartum, even when continuing pregnancy category B nucleos(t)ide analogs (NAs) treatment. However, a large proportion of the Hepatitis B virus-infected mothers were noncompliant with this breastfeeding recommendation. This study aimed to investigate the factors associated with noncompliance with breastfeeding recommendation in Hepatitis B virus-infected mothers who had received NAs treatment during pregnancy.

METHODS

A total of 155 mothers with chronic hepatitis B receiving NAs treatment for preventing mother-to-child transmission during the late gestation period were included and divided into exclusive breastfeeding (n = 63), mixed feeding (n = 34), and artificial feeding (n = 58) groups according to the postpartum feeding methods. Independent variables associated with feeding methods were analyzed using logistic regression analysis.

RESULTS

Compared to the breastfeeding and mixed feeding groups, the artificial feeding group had significantly more multiparity, later postpartum timing of stopping NAs treatment, and a lower proportion of having knowledge of NAs medications (all P < 0.05). In addition, multivariable logistic regression analysis confirmed that multiparity, later postpartum timing of stopping NAs treatment, and lacking knowledge of medication were independent factors associated with noncompliance with breastfeeding recommendation.

CONCLUSIONS

Hepatitis B virus-infected mothers who stopped NAs treatment at late postpartum period or had less knowledge of medication were more likely to be noncompliant with breastfeeding recommendation. Strengthening health education for participants taking NAs may be an important method to improve compliance with breastfeeding recommendation.

摘要

背景

我们鼓励乙型肝炎病毒(HBV)感染的母亲进行产后母乳喂养,即使她们继续接受妊娠 B 类核苷(酸)类似物(NAs)治疗。然而,很大一部分 HBV 感染的母亲不遵守这一母乳喂养建议。本研究旨在探讨在接受妊娠期间 NAs 治疗的 HBV 感染母亲中,与不遵守母乳喂养建议相关的因素。

方法

共纳入 155 例接受 NAs 治疗以预防母婴传播的慢性乙型肝炎母亲,根据产后喂养方式分为纯母乳喂养组(n=63)、混合喂养组(n=34)和人工喂养组(n=58)。采用逻辑回归分析与喂养方式相关的独立变量。

结果

与母乳喂养和混合喂养组相比,人工喂养组多胎妊娠、产后停止 NAs 治疗的时间较晚、对 NAs 药物知识的知晓率较低(均 P<0.05)。此外,多变量逻辑回归分析证实,多胎妊娠、产后停止 NAs 治疗的时间较晚、缺乏药物知识是不遵守母乳喂养建议的独立相关因素。

结论

产后晚期停止 NAs 治疗或对药物知识了解较少的 HBV 感染母亲更有可能不遵守母乳喂养建议。加强接受 NAs 治疗的参与者的健康教育可能是提高母乳喂养建议依从性的重要方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/021b/8359301/d0ed65e996df/12884_2021_4020_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/021b/8359301/d0ed65e996df/12884_2021_4020_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/021b/8359301/d0ed65e996df/12884_2021_4020_Fig1_HTML.jpg

相似文献

1
Factors associated with non-compliance with breastfeeding recommendation: a retrospective survey in hepatitis B virus-infected mothers who had taken Nucleos(t)ide analogs during pregnancy.与乙肝病毒感染母亲在孕期服用核苷(酸)类似物后不遵守母乳喂养建议相关的因素:一项回顾性调查。
BMC Pregnancy Childbirth. 2021 Aug 12;21(1):551. doi: 10.1186/s12884-021-04020-z.
2
[Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].[贵州省孕期高病毒载量及HBeAg阳性乙型肝炎病毒母婴传播阻断的临床研究]
Zhonghua Gan Zang Bing Za Zhi. 2018 Dec 20;26(12):945-950. doi: 10.3760/cma.j.issn.1007-3418.2018.12.013.
3
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.核苷(酸)类似物治疗妊娠期慢性乙型肝炎感染:系统评价。
Infect Dis (Lond). 2018 Feb;50(2):95-106. doi: 10.1080/23744235.2017.1384957. Epub 2017 Oct 11.
4
Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy.分析核苷(酸)类似物治疗慢性乙型肝炎在整个孕期的长期安全性和疗效。
Int J Infect Dis. 2021 Apr;105:626-631. doi: 10.1016/j.ijid.2021.03.023. Epub 2021 Mar 17.
5
Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.抗病毒预防治疗在妊娠期间预防乙型肝炎病毒母婴传播的疗效和安全性:系统评价和荟萃分析。
Lancet Infect Dis. 2021 Jan;21(1):70-84. doi: 10.1016/S1473-3099(20)30586-7. Epub 2020 Aug 14.
6
Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.在慢性乙型肝炎活动期孕妇的早孕中开始使用拉米夫定或替比夫定的安全性和有效性。
Hepatol Int. 2018 Mar;12(2):118-125. doi: 10.1007/s12072-017-9839-5. Epub 2018 Jan 17.
7
A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.替比夫定预防乙型肝炎病毒母婴传播的前瞻性、开放性研究:疗效和安全性评估。
J Hepatol. 2011 Dec;55(6):1215-21. doi: 10.1016/j.jhep.2011.02.032. Epub 2011 Apr 15.
8
Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.替比夫定和富马酸替诺福韦酯预防乙型肝炎垂直传播的疗效和安全性:真实世界实践。
J Viral Hepat. 2019 Oct;26(10):1170-1177. doi: 10.1111/jvh.13156. Epub 2019 Jul 4.
9
Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.比较替诺福韦和替比夫定在阻断乙型肝炎病毒母婴传播中的疗效和安全性。
Medicine (Baltimore). 2021 Nov 5;100(44):e27695. doi: 10.1097/MD.0000000000027695.
10
Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.富马酸替诺福韦二吡呋酯或替比夫定在整个孕期使用预防乙型肝炎病毒母婴传播的疗效和安全性:一项队列研究。
Eur J Obstet Gynecol Reprod Biol. 2022 Sep;276:102-106. doi: 10.1016/j.ejogrb.2022.07.009. Epub 2022 Jul 14.

引用本文的文献

1
Is health, growth and development impaired in children who are Hepatitis B-exposed but uninfected?乙肝暴露但未感染的儿童的健康、生长和发育是否会受到损害?
PLOS Glob Public Health. 2025 Aug 19;5(8):e0004984. doi: 10.1371/journal.pgph.0004984. eCollection 2025.
2
Knowledge Gaps and Current Evidence Regarding Breastfeeding Issues in Mothers with Chronic Diseases.母乳喂养问题在慢性疾病母亲中的知识差距和现有证据。
Nutrients. 2023 Jun 21;15(13):2822. doi: 10.3390/nu15132822.

本文引用的文献

1
The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancy.抗病毒治疗和停药用于预防妊娠期间 HBV 母婴传播的安全性。
J Med Virol. 2020 Dec;92(12):3381-3389. doi: 10.1002/jmv.26011. Epub 2020 Aug 2.
2
Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage.关于通过母乳喂养接触替诺福韦的指南:按发育阶段比较药物剂量。
Int J Infect Dis. 2019 Oct;87:8-12. doi: 10.1016/j.ijid.2019.07.023. Epub 2019 Jul 26.
3
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
替诺福韦与安慰剂预防乙型肝炎围产期传播的比较
N Engl J Med. 2018 Mar 8;378(10):911-923. doi: 10.1056/NEJMoa1708131.
4
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.慢性乙型肝炎的预防、诊断和治疗最新进展:美国肝病研究学会2018年乙型肝炎指南
Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800.
5
Knowledge regarding hepatitis B mother-to-child transmission among healthcare workers in South China.中国南方医护人员对乙型肝炎母婴传播的认知情况。
J Viral Hepat. 2018 May;25(5):561-570. doi: 10.1111/jvh.12839. Epub 2018 Jan 24.
6
Safety and efficacy of telbivudine for chronic hepatitis B during the entire pregnancy: Long-term follow-up.替比夫定在整个孕期治疗慢性乙型肝炎的安全性和有效性:长期随访
J Viral Hepat. 2017 Nov;24 Suppl 1:43-48. doi: 10.1111/jvh.12785.
7
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.EASL 2017 临床实践指南:乙型肝炎病毒感染管理。
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
8
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.EASL 临床实践指南:原发性胆汁性胆管炎患者的诊断和管理。
J Hepatol. 2017 Jul;67(1):145-172. doi: 10.1016/j.jhep.2017.03.022. Epub 2017 Apr 18.
9
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.替诺福韦预防高病毒载量母亲乙肝母婴传播。
N Engl J Med. 2016 Jun 16;374(24):2324-34. doi: 10.1056/NEJMoa1508660.
10
Comprehensive review of telbivudine in pregnant women with chronic hepatitis B.替比夫定用于慢性乙型肝炎孕妇的综合综述。
World J Hepatol. 2016 Mar 28;8(9):452-60. doi: 10.4254/wjh.v8.i9.452.